Skip to content
lifestyle.wordsjournal.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Cantargia
Cantargia to Host Q2 2026 Interim Results Conference Call
August 4, 2026
Cantargia Announces Changes in Number of Shares and Votes
July 31, 2026
Invitation to the Presentation of Cantargia’s Interim Report for Q1 2026
May 6, 2026
Cantargia Announces Early Results from Trial of Nadunolimab in MDS and AML
April 27, 2026
Cantargia Announces AACR 2026 Presentation of Study Design and Supportive Pre-Clinical Data for Investigator-Initiated Nadunolimab Study in MSS CRC
April 17, 2026
Notice of Annual General Meeting in Cantargia AB (publ)
April 17, 2026
Cantargia Publishes Annual Report 2025
April 17, 2026
New Preclinical Data on Anti-Tumor Effects of Nadunolimab in Metastatic Colorectal Cancer Presented at the Keystone Cancer Immunotherapy Conference
March 18, 2026
Cantargia to Participate at Van Lanschot Kempen’s Life Sciences Conference
March 5, 2026
Cantargia to Participate in TD Cowen’s Annual Healthcare Conference
February 23, 2026
1
2
Next Page
→